Details

COVID-19 has a major impact on all medical disciplines, among them hepatology. The new vaccines have potential to finally solve this global health crisis. This webinar will dive into different issues related to COVID-19 vaccination including the relative risk for severe COVID-19 in patients with chronic liver diseases (cirrhosis, metabolic and autoimmune liver disease, liver transplantation) as compared to other high-risk populations (e.g. old age), the efficacy and safety of current COVID-19 vaccines (mRNA vaccines, vector vaccines), their contraindications and limitations in patients with liver diseases. The scientific rationale for currently recommended vaccination strategies concerning patients with liver diseases will also be discussed, as well as the first outcome data of population-based vaccination in patients with and without liver diseases.

Date: 09.03.2021

Time: 18:00-19:30 CET

Register now! https://us02web.zoom.us/webinar/register/WN_Bq8s6xpMQMCu3IqqJ479DA

 

Target Audience

• Hepatologists, gastroenterologists
• General practitioners
• Health care professionals
• Clinical scientists
• Basic scientists

Learning Objectives

• Learn about the relative risk for severe COVID-19 in patients with chronic liver diseases (cirrhosis, metabolic and autoimmune liver disease, liver transplantation) as compared to other high-risk populations
• Learn about the efficacy and safety of current COVID-19 vaccines (mRNA vaccines, vector vaccines), their contraindications and limitations in patients with liver diseases
• Learn about the scientific rationale for currently recommended vaccination strategies concerning patients with liver diseases
• Learn about the first outcome data of population-based vaccination in patients with and without liver diseases

 

Programme

Time	Title
18:00-18:02	Welcome & Introduction Ulrich Spengler, University of Bonn, Germany Verena Keitel, University Hospital of Düsseldorf, Germany
18:02-18:17	Defining liver patients in urgent need of a COVID-19 vaccine for priorisation Thomas Marjot, University of Oxford, United Kingdom
18:17-18:32	Overview of the COVID-19 vaccines available in Europe Julian Schulze-zur-Wiesch, University Medical Center Hamburg-Eppendorf, Germany
18:32-18:47	Benefit/Risk of COVID-19 vaccinations: Current knowledge and how it translates to specific populations Miriam Sturkenboom, Julius Center Research Program Cardiovascular Epidemiology, Netherlands
18:47-19:02	First practical experiences with COVID-19 vaccination in Israeli patients with liver disease Rifaat Safadi, Hadassah Medical Centers of the Hebrew, University Jerusalem, Israel
19:02-19:30	Discussion and Q&A All